These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1183099)

  • 1. Testosterone therapy in hemodialysis patients.
    Ball JH; Lowrie EG; Hampers CL; Merrill JP
    Clin Nephrol; 1975; 4(3):91-8. PubMed ID: 1183099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone therapy for anaemia in maintenance dialysis.
    Shaldon S; Koch KM; Oppermann F; Patyna WD; Schoeppe W
    Br Med J; 1971 Jul; 3(5768):212-5. PubMed ID: 5559043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin activity in anephric, allotransplanted, unilaterally nephrectomized and intact man.
    Mirand EA; Murphy GP; Steeves RA; Groenewald JM; DeKlerk JN
    J Lab Clin Med; 1969 Jan; 73(1):121-8. PubMed ID: 4883100
    [No Abstract]   [Full Text] [Related]  

  • 4. [The influence of testosterone on the anaemia of terminal renal failure (author's transl)].
    Augustin HJ; Kapaun W; Kötter C
    Dtsch Med Wochenschr; 1973 Nov; 98(45):2119-22. PubMed ID: 4757967
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluoxymesterone therapy in anemia of patients on maintenance hemodialysis: comparison between patients with kidneys and anephric patients.
    Acchiardo SR; Black WD
    J Dial; 1977; 1(4):357-66. PubMed ID: 608858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of uremic patients to nandrolone decanoate.
    Doane BD; Fried W; Schwartz F
    Arch Intern Med; 1975 Jul; 135(7):972-5. PubMed ID: 1156056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular iron replenishment and replacement combined with testosterone enanthate in maintenance hemodialysis anemia: a follow-up of up to 8 years on 16 patients.
    Schustack A; Meshiaj D; Waiss Z; Gotloib L
    Clin Nephrol; 1985 Jun; 23(6):303-6. PubMed ID: 4028529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Adequacy" of haemodialysis.
    De Palma JR; Abukurah A; Rubini ME
    Proc Eur Dial Transplant Assoc; 1972; 9():265-70. PubMed ID: 4668914
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of testosterone in bilateral nephrectomized dialysis patients.
    Shaldon S; Patyna WD; Kaltwasser P; Werner E; Koch KM; Schoeppe WE
    Trans Am Soc Artif Intern Organs; 1971; 17():104-7. PubMed ID: 5158074
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of bilateral nephrectomy on transfusion requirements of patients undergoing chronic dialysis.
    Van Ypersele de Strihou ; Stragier A
    Lancet; 1969 Oct; 2(7623):705-7. PubMed ID: 4186163
    [No Abstract]   [Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of bilateral nephrectomy.
    Stenzel KH; Cheigh JS; Sullivan JF; Tapia L; Riggio RR; Rubin AL
    Am J Med; 1975 Jan; 58(1):69-75. PubMed ID: 1090153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous increase in erythropoietin and hematocrit value associated with transient liver enzyme abnormalities in an anephric patient undergoing hemodialysis.
    Brown S; Caro J; Erslev AJ; Murray TG
    Am J Med; 1980 Feb; 68(2):280-4. PubMed ID: 7355898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of bilateral nephrectomy.
    Concannon J; Lyons P; Chinitz J; Kim KE; Onesti G; Swartz C
    Proc Clin Dial Transplant Forum; 1974; (4):75-9. PubMed ID: 4619668
    [No Abstract]   [Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cells life span, splenic sequestration and transfusion requirements in chronic renal failure treated by hemodialysis. Effects of bilateral nephrectomy.
    Laurent C; Wittek M; Vereerstraeten P; Toussaint C; Naets JP
    Clin Nephrol; 1974; 2(1):35-40. PubMed ID: 4823492
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of androgens for anemia in patients on hemodialysis.
    Neff MS; Goldberg J; Slifkin RF; Eiser AR; Calamia V; Kaplan M; Baez A; Gupta S; Mattoo N
    N Engl J Med; 1981 Apr; 304(15):871-5. PubMed ID: 7010161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rate of increase in hematocrit, humoral vasoactive substances and blood pressure changes in hemodialysis patients treated with recombinant human erythropoietin or blood transfusion.
    Ono K; Hisasue Y
    Clin Nephrol; 1992 Jan; 37(1):23-7. PubMed ID: 1531789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC; Korst DR
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.